# Matson, Inc.: financial statements, quarterly

MATX · NYSE · CIK 3453 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/matx.md) · [Financials](/companies/matx/financials.md) · [Filings](/companies/matx/filings.md) · [Insiders](/companies/matx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/matx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [828](/filings/0001558370-24-013996.md) | [789 d](/filings/0001104659-26-020944.md) | [722](/filings/0001558370-25-006367.md) | [847](/filings/0001558370-25-009928.md) | [962](/filings/0001104659-25-106604.md) | [890 d](/filings/0001104659-26-020944.md) | [782](/filings/0001104659-26-055178.md) | [831](/filings/0001104659-26-090003.md) | [880](/filings/0001104659-25-106604.md) | [852 d](/filings/0001104659-26-020944.md) | [758](/filings/0001104659-26-055178.md) | [969](/filings/0001104659-26-090003.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [72.6](/filings/0001558370-24-013996.md) | [73.3 d](/filings/0001558370-24-001570.md) | [73.4](/filings/0001558370-24-006316.md) | [77.1](/filings/0001558370-24-010642.md) | [72.3](/filings/0001558370-24-013996.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [132](/filings/0001558370-24-013996.md) | [75.3 d](/filings/0001104659-26-020944.md) | [36.9](/filings/0001558370-25-006367.md) | [125](/filings/0001558370-25-009928.md) | [242](/filings/0001104659-25-106604.md) | [148 d](/filings/0001104659-26-020944.md) | [82.1](/filings/0001104659-26-055178.md) | [113](/filings/0001104659-26-090003.md) | [161](/filings/0001104659-25-106604.md) | [144 d](/filings/0001104659-26-020944.md) | [61.4](/filings/0001104659-26-055178.md) | [159](/filings/0001104659-26-090003.md) |
| Interest expense | $m | [2.4](/filings/0001558370-24-013996.md) | [2.4 d](/filings/0001558370-24-001570.md) | [2.2](/filings/0001558370-24-006316.md) | [2.1](/filings/0001558370-24-010642.md) | [1.8](/filings/0001558370-24-013996.md) | [1.4 d](/filings/0001104659-26-020944.md) | [1.7](/filings/0001104659-26-055178.md) | [1.7](/filings/0001104659-26-090003.md) | [1.8](/filings/0001104659-25-106604.md) | [1.6 d](/filings/0001104659-26-020944.md) | [1.6](/filings/0001104659-26-055178.md) | [1.6](/filings/0001104659-26-090003.md) |
| Income tax | $m | [20.3](/filings/0001558370-24-013996.md) | [21.9 d](/filings/0001104659-26-020944.md) | [9.2](/filings/0001558370-25-006367.md) | [29.9](/filings/0001558370-25-009928.md) | [53.7](/filings/0001104659-25-106604.md) | [30.2 d](/filings/0001104659-26-020944.md) | [19.9](/filings/0001104659-26-055178.md) | [27.0](/filings/0001104659-26-090003.md) | [34.2](/filings/0001104659-25-106604.md) | [7.9 d](/filings/0001104659-26-020944.md) | [11.3](/filings/0001104659-26-055178.md) | [34.5](/filings/0001104659-26-090003.md) |
| Net income | $m | [120](/filings/0001558370-24-013996.md) | [62.4 d](/filings/0001104659-26-020944.md) | [36.1](/filings/0001104659-25-106604.md) | [113](/filings/0001104659-25-106604.md) | [199](/filings/0001104659-25-106604.md) | [128 d](/filings/0001104659-26-020944.md) | [72.3](/filings/0001104659-26-090003.md) | [94.7](/filings/0001104659-26-090003.md) | [135](/filings/0001104659-25-106604.md) | [143 d](/filings/0001104659-26-020944.md) | [56.6](/filings/0001104659-26-090003.md) | [129](/filings/0001104659-26-090003.md) |
| Diluted EPS | $ per share | [3.40](/filings/0001558370-24-013996.md) | not reported | [1.04](/filings/0001558370-25-006367.md) | [3.31](/filings/0001558370-25-009928.md) | [5.89](/filings/0001104659-25-106604.md) | not reported | [2.18](/filings/0001104659-26-055178.md) | [2.92](/filings/0001104659-26-090003.md) | [4.24](/filings/0001104659-25-106604.md) | not reported | [1.85](/filings/0001104659-26-055178.md) | [4.27](/filings/0001104659-26-090003.md) |
| Basic EPS | $ per share | [3.42](/filings/0001558370-24-013996.md) | not reported | [1.05](/filings/0001558370-25-006367.md) | [3.34](/filings/0001558370-25-009928.md) | [5.98](/filings/0001104659-25-106604.md) | not reported | [2.20](/filings/0001104659-26-055178.md) | [2.95](/filings/0001104659-26-090003.md) | [4.28](/filings/0001104659-25-106604.md) | not reported | [1.86](/filings/0001104659-26-055178.md) | [4.30](/filings/0001104659-26-090003.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [157](/filings/0001558370-24-013996.md) | [134](/filings/0001104659-26-020944.md) | [25.9](/filings/0001558370-25-006367.md) | [168](/filings/0001558370-25-009928.md) | [270](/filings/0001104659-25-106604.md) | [267](/filings/0001104659-26-020944.md) | [122](/filings/0001558370-25-006367.md) | [59.1](/filings/0001558370-25-009928.md) | [92.7](/filings/0001104659-25-106604.md) | [142](/filings/0001104659-26-090003.md) | [100](/filings/0001104659-26-055178.md) | [119](/filings/0001104659-26-090003.md) |
| Current assets | $m | [636](/filings/0001558370-23-017049.md) | [602](/filings/0001558370-25-001875.md) | [512](/filings/0001558370-24-006316.md) | [546](/filings/0001558370-24-010642.md) | [652](/filings/0001558370-24-013996.md) | [610](/filings/0001104659-26-020944.md) | [468](/filings/0001558370-25-006367.md) | [425](/filings/0001558370-25-009928.md) | [447](/filings/0001104659-25-106604.md) | [472](/filings/0001104659-26-090003.md) | [436](/filings/0001104659-26-055178.md) | [536](/filings/0001104659-26-090003.md) |
| Total assets | $m | [4,293](/filings/0001558370-23-017049.md) | [4,295](/filings/0001558370-25-001875.md) | [4,220](/filings/0001558370-24-006316.md) | [4,274](/filings/0001558370-24-010642.md) | [4,442](/filings/0001558370-24-013996.md) | [4,595](/filings/0001104659-26-020944.md) | [4,527](/filings/0001558370-25-006367.md) | [4,482](/filings/0001558370-25-009928.md) | [4,602](/filings/0001104659-25-106604.md) | [4,636](/filings/0001104659-26-090003.md) | [4,583](/filings/0001104659-26-055178.md) | [4,714](/filings/0001104659-26-090003.md) |
| Current liabilities | $m | [571](/filings/0001558370-23-017049.md) | [562](/filings/0001558370-25-001875.md) | [531](/filings/0001558370-24-006316.md) | [585](/filings/0001558370-24-010642.md) | [578](/filings/0001558370-24-013996.md) | [560](/filings/0001104659-26-020944.md) | [546](/filings/0001558370-25-006367.md) | [547](/filings/0001558370-25-009928.md) | [541](/filings/0001104659-25-106604.md) | [527](/filings/0001104659-26-090003.md) | [530](/filings/0001104659-26-055178.md) | [604](/filings/0001104659-26-090003.md) |
| Long-term debt | $m | [399](/filings/0001558370-23-017049.md) | [389](/filings/0001558370-25-001875.md) | [379](/filings/0001558370-24-006316.md) | [370](/filings/0001558370-24-010642.md) | [360](/filings/0001558370-24-013996.md) | [351](/filings/0001104659-26-020944.md) | [341](/filings/0001558370-25-006367.md) | [332](/filings/0001558370-25-009928.md) | [322](/filings/0001104659-25-106604.md) | [312](/filings/0001104659-26-090003.md) | [302](/filings/0001104659-26-055178.md) | [293](/filings/0001104659-26-090003.md) |
| Current portion of debt | $m | [39.7](/filings/0001558370-23-017049.md) | [39.7](/filings/0001558370-25-001875.md) | [39.7](/filings/0001558370-24-006316.md) | [39.7](/filings/0001558370-24-010642.md) | [39.7](/filings/0001558370-24-013996.md) | [39.7](/filings/0001104659-26-020944.md) | [39.7](/filings/0001558370-25-006367.md) | [39.7](/filings/0001558370-25-009928.md) | [39.7](/filings/0001104659-25-106604.md) | [39.7](/filings/0001104659-26-090003.md) | [39.7](/filings/0001104659-26-055178.md) | [39.7](/filings/0001104659-26-090003.md) |
| Short-term borrowings | $m | [39.7](/filings/0001558370-23-017049.md) | [39.7](/filings/0001558370-25-001875.md) | [39.7](/filings/0001558370-24-006316.md) | [39.7](/filings/0001558370-24-010642.md) | [39.7](/filings/0001558370-24-013996.md) | [39.7](/filings/0001104659-26-020944.md) | [39.7](/filings/0001558370-25-006367.md) | [39.7](/filings/0001558370-25-009928.md) | [39.7](/filings/0001104659-25-106604.md) | [39.7](/filings/0001104659-26-090003.md) | [39.7](/filings/0001104659-26-055178.md) | [39.7](/filings/0001104659-26-090003.md) |
| Shareholders' equity | $m | [2,390](/filings/0001558370-24-013996.md) | [2,401](/filings/0001104659-26-020944.md) | [2,374](/filings/0001104659-25-106604.md) | [2,399](/filings/0001104659-25-106604.md) | [2,557](/filings/0001104659-25-106604.md) | [2,652](/filings/0001104659-26-090003.md) | [2,633](/filings/0001104659-26-090003.md) | [2,618](/filings/0001104659-26-090003.md) | [2,689](/filings/0001104659-25-106604.md) | [2,759](/filings/0001104659-26-090003.md) | [2,730](/filings/0001104659-26-090003.md) | [2,773](/filings/0001104659-26-090003.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [153 d](/filings/0001558370-24-013996.md) | [111 d](/filings/0001104659-26-020944.md) | [36.6](/filings/0001558370-25-006367.md) | [308 d](/filings/0001558370-25-009928.md) | [249 d](/filings/0001104659-25-106604.md) | [175 d](/filings/0001104659-26-020944.md) | [89.0](/filings/0001104659-26-055178.md) | [106 d](/filings/0001104659-26-090003.md) | [176 d](/filings/0001104659-25-106604.md) | [177 d](/filings/0001104659-26-020944.md) | [94.0](/filings/0001104659-26-055178.md) | [138 d](/filings/0001104659-26-090003.md) |
| Capital expenditure | $m | not reported | not reported | [55.3](/filings/0001558370-25-006367.md) | [69.8](/filings/0001558370-25-009928.md) | [59.6](/filings/0001104659-25-106604.md) | [125 d](/filings/0001104659-26-020944.md) | [89.2](/filings/0001104659-26-055178.md) | [86.3](/filings/0001558370-25-009928.md) | [83.2](/filings/0001104659-25-106604.md) | [135 d](/filings/0001104659-26-020944.md) | [48.3](/filings/0001104659-26-055178.md) | not reported |
| Dividends paid | $m | [11.4 d](/filings/0001558370-24-013996.md) | [11.2 d](/filings/0001104659-26-020944.md) | [11.1](/filings/0001558370-25-006367.md) | [11.0 d](/filings/0001558370-25-009928.md) | [11.4 d](/filings/0001104659-25-106604.md) | [11.3 d](/filings/0001104659-26-020944.md) | [11.3](/filings/0001104659-26-055178.md) | [11.0 d](/filings/0001104659-26-090003.md) | [11.4 d](/filings/0001104659-25-106604.md) | [11.2 d](/filings/0001104659-26-020944.md) | [11.0](/filings/0001104659-26-055178.md) | [11.0 d](/filings/0001104659-26-090003.md) |
| Share repurchases | $m | [25.7 d](/filings/0001558370-24-013996.md) | [47.0 d](/filings/0001104659-26-020944.md) | [47.3](/filings/0001558370-25-006367.md) | [72.8 d](/filings/0001558370-25-009928.md) | [47.3 d](/filings/0001104659-25-106604.md) | [31.7 d](/filings/0001104659-26-020944.md) | [66.9](/filings/0001104659-26-055178.md) | [93.5 d](/filings/0001104659-26-090003.md) | [65.4 d](/filings/0001104659-25-106604.md) | [77.5 d](/filings/0001104659-26-020944.md) | [52.8](/filings/0001104659-26-055178.md) | [67.0 d](/filings/0001104659-26-090003.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [38.6](/filings/0001558370-23-017049.md) | [36.3](/filings/0001558370-24-006316.md) | [35.7](/filings/0001558370-24-010642.md) | [35.3](/filings/0001558370-24-013996.md) | [34.6](/filings/0001558370-25-006367.md) | [34.2](/filings/0001558370-25-009928.md) | [33.8](/filings/0001104659-25-106604.md) | [33.2](/filings/0001104659-26-055178.md) | [32.4](/filings/0001104659-26-090003.md) | [31.8](/filings/0001104659-25-106604.md) | [30.6](/filings/0001104659-26-055178.md) | [30.3](/filings/0001104659-26-090003.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 29,903,458 at 2026-06-30, from the cover of the [10-Q filed 2026-08-04](/filings/0001104659-26-090003.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.